Atorvastatin is a medication that inhibits the HMG-CoA reductase enzyme. Hanmi Pharmaceutical Co., Ltd approved it in January 2008. It is used to treat hyperlipidemias, which is a condition characterized by elevated cholesterol and triglycerides in the blood. Atorvastatin belongs to a class of drugs known as HMG-CoA reductase inhibitors, also known as statins. These medications work by preventing the enzyme responsible for producing cholesterol in the liver from functioning. By lowering cholesterol levels in the blood, atorvastatin helps reduce the risk of heart disease and stroke. The medication is generally well-tolerated, but some patients may experience side effects such as muscle pain, weakness, and liver dysfunction. Click on the image below to begin the exploration journey of Atorvastatin through the Synapse database!
You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!